View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOJ/DEA RIN: 1117-AB74 Publication ID: Fall 2024 
Title: Federal Regulations on Telepharmacy 
Abstract:

DEA is considering promulgating regulations regarding telepharmacy.  Telepharmacy is not specifically defined by the Controlled Substances Act (CSA) or DEA regulations; however, to the extent telepharmacies dispense controlled substances, they are under the purview of the CSA and DEA.

 
Agency: Department of Justice(DOJ)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: Not Yet Determined     (To search for a specific CFR, visit the Code of Federal Regulations.)
Legal Authority: 21 U.S.C. 822    21 U.S.C. 823    21 U.S.C. 871(b)    21 U.S.C. 958(f)   
Legal Deadline:  None
Timetable:
Action Date FR Cite
ANPRM  11/17/2021  86 FR 64096   
ANPRM Comment Period End  01/18/2022 
NPRM  09/00/2025 
Additional Information: DEA Docket number 759
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
RIN Information URL: DPW@dea.gov   Public Comment URL: www.regulations.gov  
RIN Data Printed in the FR: No 
Agency Contact:
Heather E Achbach
Acting Section Chief, Regulatory Drafting and Support Section
Department of Justice
Drug Enforcement Administration
Diversion Control Division, 8701 Morrissette Drive,
Springfield, VA 22152
Phone:571 387-3185
Email: heather.e.achbach@dea.gov